Cholesterol in signal transduction

Current Opinion in Cell Biology

Volumn 12, Issue 2, 2000, Pages 193-203

  Incardona, John P ^a   Eaton, Suzanne ^b,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^c MAX PLANCK INSTITUTE OF MOLECULAR CELL BIOLOGY AND GENETICS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN; CHOLESTEROL; MEMBRANE LIPID; RECEPTOR; SONIC HEDGEHOG PROTEIN;

CELL MEMBRANE; CHOLESTEROL TRANSPORT; ENDOCYTOSIS; LIPID TRANSPORT; PRIORITY JOURNAL; PROTEIN TRANSPORT; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION;

ERINACEIDAE;

EID: 0034092240     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(99)00076-9     Document Type: Review

References (97)

1. Rietveld A.G., Simons K. The differential miscibility of lipids as the basis for the formation of functional membrane rafts. Biochem Biophys Acta. 376:1998;467-479.
2. Simons K., Ikonen E. Functional rafts in cell membranes. Nature. 387:1997;569-572.
3. Gimpl G., Burger K., Fahrenholz F. Cholesterol as modulator of receptor function. Biochemistry. 36:1997;10959-10974.
4. Osborne T.F., Rosenfeld J.M. Related membrane domains in proteins of sterol sensing and cell signaling provide a glimpse of treasures still buried within the dynamic realm of intracellular metabolic regulation. Curr Opin Lipidol. 9:1998;137-140.
5. Kerszberg M. Morphogen propagation and action: towards molecular models. Semin Cell Dev Biol. 10:1999;297-302.
6. Porter J.A., Ekker S.C., Park W.J., von Kessler D.P., Young K.E., Chen C.H., Ma Y., Woods A.S., Cotter R.J., Koonin E.V., Beachy P.A. Hedgehog patterning activity: role of a lipophilic modification mediated by the carboxy-terminal autoprocessing domain. Cell. 86:1996;21-34.
7. Porter J.A., Young K.E., Beachy P.A. Cholesterol modification of hedgehog signaling proteins in animal development. Science. 274:1996;255-259.
8. Pepinsky R.B., Zeng C., Wen De Rayhorn P., Baker D.P., Williams K.P., Bixler S.A., Ambrose C.M., Garber E.A., Miatowski K.et al. Identification of a palmitic acid-modified form of human Sonic hedgehog. J Biol Chem. 273:1998;14037-14045. This paper shows that Shh undergoes a second post-translational modification in addition to the cholesterol adduct. A palmitate molecule is attached to an amino-terminal cysteine residue, which is unusual for a protein oriented on the cytoplasmic face of the plasma membrane. The fraction of Shh receiving this modification varies according to cell type. Furthermore, it occurs more efficiently if the protein is modified by cholesterol: truncated forms of Shh that lack the cholesterol-addition site are less likely to be acylated, and fatty acids other than palmitate are incorporated. These authors also demonstrate that purified lipid-linked Shh is 30-fold more potent than unmodified Shh, despite having the same binding affinity for Ptc.
9. Rietveld A., Neutz S., Simons K., Eaton S. Association of sterol- and glycosylphosphatidylinositol-linked proteins with Drosophila raft lipid microdomains. J Biol Chem. 274:1999;12049-12054. Rafts previously have been described only in mammalian cells. Drosophila embryos are interesting in that they incorporate sterols derived from dietary yeast, rather than synthesizing cholesterol. These authors show that insect cells possess rafts of very similar composition to mammalian cells, despite differences in sterols and specific lipid chain lengths and the lower temperatures at which flies live. Furthermore, the lipid modification of Hh was demonstrated to mediate raft association.
10. Briscoe J., Ericson J. The specification of neuronal identity by graded sonic hedgehog signalling. Semin Cell Dev Biol. 10:1999;353-362.
11. Ingham P.W. Transducing Hedgehog: the story so far. EMBO J. 17:1998;3505-3511.
12. Murone M., Rosenthal A., de Sauvage F.J. Hedgehog signal transduction: from flies to vertebrates. Exp Cell Res. 253:1999;25-33.
13. Carstea E.D., Morris J.A., Coleman K.G., Loftus S.K., Zhang D., Cummings C., Gu J., Rosenfeld M.A., Pavan W.J., Krizman D.B.et al. Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science. 277:1997;228-231.
14. Loftus S.K., Morris J.A., Carstea E.D., Gu J.Z., Cummings C., Brown A., Ellison J., Ohno K., Rosenfeld M.A., Tagle D.A.et al. Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene. Science. 277:1997;232-235.
15. Neufeld E.B., Wastrey M., Patel S., Suresh S., Cooeney A.M., Dwyer N.K., Roff C.F., Ohno K., Morris J.A., Carstea E.D.et al. The Niemann-Pick C1 protein resides in a vesicular compartment linked to retrograde transport of multiple lysosomal cargo. J Biol Chem. 274:1999;9627-9635. Although a decade of research had suggested that the gene affected in NP-C disease would play a crucial role in cholesterol homeostasis, the definitive answer awaited the cloning of NPC1. This paper demonstrates that NPC1 is a protein found on late endosomal vesicles that are, surprisingly, relatively cholesterol poor. Effects of cholesterol transport-blocking drugs are correlated with effects on NPC1 trafficking. These data suggested that regulation of cholesterol distribution by NPC1 involves transient interactions with cholesterol-rich vesicles, and brings the field of cholesterol transport to a new level of experimentation.
16. Higgins M.E., Davies J.P., Chen F.W., Ioannou Y.A. Niemann-Pick C1 is a late endosome-resident protein that transiently associates with lysosomes and the trans-Golgi network. Mol Genet Metab. 68:1999;1-13.
17. Roessler E., Muenke M. Holoprosencephaly: a paradigm for the complex genetics of brain development. J Inherit Metab Dis. 21:1998;481-497.
18. Siebert J.R., Cohen M.M. Jr., Sulik K.K., Shaw M-C., Lemire R.J. Holoprosencephaly: Overview and Atlas of Cases. 1990;Wiley-Liss, New York.
19. Chiang C., Litingtung Y., Lee E., Young K.E., Corden J.L., Westphal H., Beachy P.A. Cyclopia and defective axial patterning in mice lacking Sonic hedgehog gene function. Nature. 383:1996;407-413.
20. Roessler E., Belloni E., Gaudenz K., Jay P., Berta P., Scherer S.W., Tsui L.C., Muenke M. Mutations in the human Sonic Hedgehog gene cause holoprosencephaly. Nat Genet. 14:1996;357-360.
21. Gaffield W., Keeler R.F. Steroidal alkaloid teratogens: molecular probes for investigation of craniofacial malformations. J Toxicol. 15:1996;303-326.
22. James L.F. Teratological research at the USDA-ARS poisonous plant research laboratory. J Nat Toxins. 8:1999;63-80.
23. Roux C., Aubry M. Action teratogene chez le rat d'un inhibiteur de la synthese du cholesterol, le AY 9944. C R Seances Soc Biol Fil. 160:1966;1353-1357.
24. Kelley R.L., Roessler E., Hennekam R.C., Feldman G.L., Kosaki K., Jones M.C., Palambos J.C., Muenke M. Holoprosencephaly in RSH/Smith-Lemli-Opitz syndrome: does abnormal cholesterol metabolism affect the function of Sonic Hedgehog? Am J Med Genet. 66:1996;478-484.
25. Tint G.S., Irons E.R., Elias A.K., Batta A.K., Frieden R., Chen T.S., Salen G. Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. N Engl J Med. 330:1994;107-113.
26. Fitzky B.U., Witsch Baumgartner M., Erdel M., Lee J.N., Paik Y.K., Glossman H., Utermann G., Moebius F.F. Mutations in the Delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome. Proc Natl Acad Sci USA. 95:1998;8181-8186.
27. Wolf C., Chevy F., Pham J., Kolf Clauw M., Citadella D., Mulliez N., Roux C. Changes in serum sterols of rats treated with 7-dehydrocholesterol-delta 7-reductase inhibitors: comparison to levels in humans with Smith-Lemli-Opitz syndrome. J Lipid Res. 37:1996;1325-1333.
28. Willnow T.E., Hilpert J., Armstrong S.A., Rohlmann A., Hammer R.E., Burns D.E., Herz J. Defective forebrain development in mice lacking gp330/megalin. Proc Natl Acad Sci USA. 93:1996;8460-8464.
29. Cooper M.K., Porter J.A., Young K.E., Beachy P.A. Teratogen-mediated inhibition of target tissue response to Shh signaling. Science. 280:1998;1603-1607. An earlier hypothesis for the action of holoprosencephaly inducing compounds suggested that they acted on the cholesterol modification of Shh. This paper demonstrates that multiple sterols can partake in the in vitro modification reaction, including precursors associated with reduced 7DHCR activity, and that the teratogens do not affect the processing reaction in cells. Instead, the cholesterol synthesis inhibitor AY-9944, Veratrum steroidal alkaloids and compounds known to block cholesterol transport all inhibit the cellular responses to Shh, and the authors propose a common mechanism for the effects.
30. Incardona J.P., Gaffield W., Kapur R.P., Roelink H. The teratogenic Veratrum alkaloid cyclopamine inhibits Sonic Hedgehog signal transduction. Development. 125:1998;3553-3562. The authors demonstrate that holoprosencephaly in cyclopamine-treated embryos is associated with a failure of Shh signaling in the neural tube. These authors also analyze the relationship of cholesterol metabolism in neural tissue to the teratogenic effects of cyclopamine and AY-9944. The data indicate that cyclopamine and AY-9944 do not affect Shh signaling through an identical mechanism. The inhibition of Shh signaling by cyclopamine was unaffected by manipulation of tissue cholesterol supplies, in contrast to the inhibition by AY-9944. The effects of AY-9944 are probably secondary to sterol precursor accumulation, whereas cyclopamine antagonizes Shh signal transduction more directly.
31. Nohturfft A., Brown M.S., Goldstein J.L. Sterols regulate processing of carbohydrate chains of wild-type SREBP cleavage-activating protein (SCAP), but not sterol-resistant mutants Y298C or D443N. Proc Natl Acad Sci USA. 95:1998;12848-12853.
32. Nohturfft A., DeBose-Boyd R.A., Scheek S., Goldstein J.L., Brown M.S. Sterols regulate cycling of SREBP cleavage-activating protein (SCAP) between endoplasmic reticulum and Golgi. Proc Natl Acad Sci USA. 96:1999;11235-11240.
33. Brown D.A., London E. Structure of detergent-resistant membrane domains: does phase separation occur in biological membranes? Biochem Biophys Res Commun. 240:1997;1-7.
34. Brown D.A., London E. Functions of lipid rafts in biological membranes. Annu Rev Cell Dev Biol. 14:1998;111-136.
35. Ahmed S.N., Brown D.A., London E. On the origin of sphingolipid/cholesterol-rich detergent-insoluble cell membranes: physiological concentrations of cholesterol and sphingolipid induce formation of a detergent-insoluble, liquid-ordered lipid phase in model membranes. Biochemistry. 36:1997;10944-10953.
36. Schroeder R.J., Ahmed S.N., Zhu Y., London E., Brown D.A. Cholesterol and sphingolipid enhance the Triton X-100 insolubility of glycosylphosphatidylinositol-anchored proteins by promoting the formation of detergent-insoluble ordered membrane domains. J Biol Chem. 273:1998;1150-1157.
37. Ge M., Field K.A., Aneja R., Holowka D., Baird B., Freed J.H. Electron spin resonance characterization of liquid ordered phase of detergent-resistant membranes from RBL-2H3 cells. Biophys J. 77:1999;925-933.
38. Varma R., Mayor S. GPI-anchored proteins are organized in submicron domains at the cell surface. Nature. 394:1998;798-801. Before these studies there was no direct evidence that rafts exist in living cells. These authors measure fluorescence energy transfer between folate receptors bound to a fluorescent analogue of folic acid. The extent of energy transfer for GPI-anchored folate-receptor is density independent, indicative of sub-pixel-sized domains, whereas the extent of energy transfer for transmembrane-anchored folate receptor is density dependent, consistent with a random distribution. Removal of cellular cholesterol disrupted the domains containing the GPI-anchored folate receptor. These results indicated that lipid-linked proteins on live cells are organized in cholesterol-dependent domains of ~70 nm diameter.
39. Friedrichson T., Kurzchalia T.V. Microdomains of GPI-anchored proteins in living cells revealed by crosslinking. Nature. 394:1998;802-805. These authors use chemical crosslinking to show that GPI-anchored growth hormone formed oligomers, supporting the existence of membrane microdomains at the surface of living cells. This clustering is found to be specific for the GPI-anchored form, as two transmembrane forms of growth hormone do not form oligomers. Depletion of membrane cholesterol cause the unclustering of GPI-anchored proteins, whereas treatment of cells with detergent substantially increased the size of the complexes. GPI-anchored proteins are found in microdomains consisting of at least 15 molecules.
40. Sheets E.D., Holowka D., Baird B. Membrane organization in immunoglobulin E receptor signaling. Curr Opin Chem Biol. 3:1999;95-99.
41. Sheets E.D., Holowka D., Baird B. Critical role for cholesterol in Lyn-mediated tyrosine phosphorylation of FcepsilonRI and their association with detergent-resistant membranes. J Cell Biol. 145:1999;877-887.
42. van't Hof W., Resh M.D. Dual fatty acylation of p59(Fyn) is required for association with the T cell receptor zeta chain through phosphotyrosine-Src homology domain-2 interactions. J Cell Biol. 145:1999;377-389.
43. Ferguson S.S., Caron M.G. G protein-coupled receptor adaptation mechanisms. Semin Cell Dev Biol. 9:1998;119-127.
44. Waterman H., Sabanai I., Geiger B., Yarden Y. Alternative intracellular routing of ErbB receptors may determine signaling potency. J Biol Chem. 273:1998;13819-13827.
45. Waterman H., Alroy I., Strano S., Seger R., Yarden Y. The C-terminus of the kinase-defective neuregulin receptor ErbB-3 confers mitogenic superiority and dictates endocytic routing. EMBO J. 18:1999;3348-3358.
46. Lenferink A.E., Pinkas-Kramarski R., van de Poll M.L., van Vugt M.J., Klapper Z.N., Tzahar R.E., Waterman H., Sela H., van Zoelen E.J., Yarden Y. Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers. EMBO J. 17:1998;3385-3397.
47. Mukherjee S., Soe T.T., Maxfield F.R. Endocytic sorting of lipid analogues differing solely in the chemistry of their hydrophobic tails. J Cell Biol. 144:1999;1271-1284. These authors investigated the intracellular trafficking of three lipid-mimetic Dil derivatives, DilC16 and FAST Dil. The three Dils differed only in their alkyl tail length or unsaturation, which was expected to affect their distribution in membrane domains of varying fluidity or curvature. All three Dils initially entered sorting endosomes containing endocytosed transferrin. However, DilC16, with two long 16-carbon saturated tails, was subsequently delivered to late endosomes, whereas DilC12, with saturated but shorter tails, were found mainly in the endocytic recycling compartment. These and other findings suggest that endocytic organelles can sort lipids efficiently on the basis of their preference for association with domains of varying characteristics.
48. Mukherjee S., Zha X., Tabas I., Maxfield F.R. Cholesterol distribution in living cells: fluorescence imaging using dehydroergosterol as a fluorescent cholesterol analog. Biophys J. 75:1998;1915-1925.
49. Mayor S., Sabharanjak S., Maxfield F.R. Cholesterol-dependent retention of GPI-anchored proteins in endosomes. EMBO J. 17:1998;4626-4638. Using several methods, these authors show that GPI-anchored proteins are internalized into endosomes that contain markers for both receptor-mediated uptake (e.g. transferrin) and fluid phase endocytosis (e.g. dextrans). However, most of the GPI-anchored proteins are found to recycle back to the plasma membrane at a rate at least three-fold slower than recycling transferrin receptors. This retention is regulated by the level of cholesterol in cell membranes, because GPI-anchored proteins and transferrin receptors are recycled to the cell surface at the same rate in cholesterol-depleted cells. These data indicate a role for rafts in endocytic sorting.
50. Fielding C.J., Fielding P.E. Intracellular cholesterol transport. J Lipid Res. 38:1997;1503-1521.
51. Engelman J.A., Chu C., Lin H., Jo H., Ikezu T., Okamoto T., Kohtz D.S., Lisanti M.P. Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain. FEBS Lett. 428:1998;205-211.
52. Galbiati F., Volante D., Engelman J.A., Watnabe G., Burk R., Pestell R.G., Lisanti M.P. Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. EMBO J. 17:1998;6633-6648.
53. Scheel J., Srinivasan J., Honnert U., Henske A., Kurzchalia T.V. Involvement of caveolin-1 in meiotic cell-cycle progression in Caenorhabditis elegans. Nat Cell Biol. 1:1999;127-129.
54. Yamamoto M., Toya Y., Schwencke C., Lisanti M.P., Myers M.G. Jr., Ishikawa Y. Caveolin is an activator of insulin receptor signaling. J Biol Chem. 273:1998;26962-26968.
55. Razani B., Rubin C.S., Lisanti M.P. Regulation of cAMP-mediated signal transduction via interaction of caveolins with the catalytic subunit of protein kinase A. J Biol Chem. 274:1999;26353-26360.
56. Okamoto T., Schlegel A., Scherer P.E., Lisanti M.P. Caveolins, a family of scaffolding proteins for organizing 'preassembled signaling complexes' at the plasma membrane. J Biol Chem. 273:1998;5419-5422.
57. Smart E.J., Ying Y., Donzell D.C., Anderson R.G. A role for caveolin in transport of cholesterol from endoplasmic reticulum to plasma membrane. J Biol Chem. 271:1996;29427-29435.
58. Fielding C.J., Bist A., Fielding P.E. Intracellular cholesterol transport in synchronized human skin fibroblasts. Biochemistry. 38:1999;2506-2513.
59. DGV completely blocks signaling mediated by H-Ras, but not that mediated by K-Ras. This inhibitory effect is reversed by replenishing cell membranes with cholesterol and was mimicked by cyclodextrin treatment, which depletes membrane cholesterol. These results provide a crucial link between the cholesterol-trafficking role of caveolin and its postulated role in signal transduction through raft membrane subdomains.
60. Song S.K., Li S., Okamoto T., Quilliam L.A., Sargiacomo M., Lisanti M.P. Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains. J Biol Chem. 271:1996;9690-9697.
61. Hua X., Nohturfft A., Goldstein J.L., Brown M.S. Sterol resistance in CHO cells traced to point mutation in SREBP cleavage-activating protein. Cell. 87:1996;415-426.
62. Gemmill R.M., West J.D., Boldog F., Tanaka N., Robinson L.J., Smith D.I., Li F., Drabkin H.A. The hereditary renal cell carcinoma 3;8 translocation fuses FHIT to a patched-related gene, TRC8. Proc Natl Acad Sci USA. 95:1998;9572-9577.
63. Bae S.H., Lee J.N., Fitzky B.U., Seong J., Paik Y.K. Cholesterol biosynthesis from lanosterol. Molecular cloning, tissue distribution, expression, chromosomal localization, and regulation of rat 7-dehydrocholesterol reductase, a Smith-Lemli-Opitz syndrome-related protein. J Biol Chem. 274:1999;14624-14631.
64. Burke R., Nellen D., Bellotto M., Hafen E., Senti K-A., Dickson B.J., Basler K. Dispatched, a novel sterol-sensing domain protein dedicated to the release of cholesterol-modified hedgehog from signaling cells. Cell. 99:1999;803-815.
65. Gil G., Faust J.R., Chin D.J., Goldstein J.L., Brown M.S. Membrane-bound domain of HMG CoA reductase is required for sterol-enhanced degradation of the enzyme. Cell. 41:1985;249-258.
66. Kumagai H., Chun K.T., Simoni R.D. Molecular dissection of the role of the membrane domain in the regulated degradation of 3-hydroxy-3-methylglutaryl coenzyme A reductase. J Biol Chem. 270:1995;19107-19113.
67. Blanchette-Mackie E.J., Dwyer N.K., Amende L.M., Kruth H.S., Butler J.D., Sokol J., Comly M.E., Vanzer M.T., August J.T., Brady R.O., Pentchev P.G. Type-C Niemann-Pick disease: low density lipoprotein uptake is associated with premature cholesterol accumulation in the Golgi complex and excessive cholesterol storage in lysosomes. Proc Natl Acad Sci USA. 85:1988;8022-8026.
68. Liscum L., Faust J.R. Low density lipoprotein (LDL)-mediated suppression of cholesterol synthesis and LDL uptake is defective in Niemann-Pick type C fibroblasts. J Biol Chem. 262:1987;17002-17008.
69. Vanier M.T. Lipid changes in Niemann-Pick disease type C brain: personal experience and review of the literature. Neurochem Res. 24:1999;481-489.
70. Kobayashi T., Beuchat M-H., Lindsay M., Frias S., Palmiter R.D., Sakuraba H., Parton R.G., Gruenberg J. Late endosomal membranes rich in lysobisphosphatidic acid regulate cholesterol transport. Nat Cell Biol. 1:1999;113-118. In cells from Niemann-Pick type C patients and drug-treated cells that mimic NP-C, cholesterol accumulates in late endosomes rather than lysosomes. Cholesterol accumulates within the previously identified network of LBPA-rich membranes within multivesicular late endosomes. Furthermore, antibodies against LBPA induce the same defects as the NP-C-mimicking drug U18666A, which includes impairment of mannose-6-phosphate receptor sorting.
71. Kobayashi T., Stang E., Fang K.S., de Moerloose P., Parton R.G., Gruenberg J. A lipid associated with the antiphospholipid syndrome regulates endosome structure and function. Nature. 392:1998;193-197.
72. Watari H., Blanchette-Mackie E.J., Dwyer N.K., Watan M., Neufeld E.B., Patel S., Pentchev P.G., Strauss J.F.I. Mutations in the leucine zipper motif and sterol-sensing domain inactivate the Niemann-Pick C1 glycoprotein. J Biol Chem. 274:1999;21861-21866. These authors use rescue of the NP-C cellular phenotype by transfection to assess the function of a number of site-directed NPC1 mutations. Mutations in the sterol-sensing domain result in inactive proteins targeted to lysosomal membranes encircling cholesterol-laden cores but failing to correct the NP-C defect. Amino-terminal leucine-zipper motif mutants also cannot correct the NP-C defect, although they accumulate in lysosomal membranes. Thus, the sterol-sensing domain and leucine-zipper motif are required for cholesterol-mobilizing activity of NPC1.
73. Rodriguez-Lafrasse C., Rousson R., Bonnet J., Pentchev P.G., Louisot P., Vanier M.T. Abnormal cholesterol metabolism in imipramine-treated fibroblast cultures. Similarities with Niemann-Pick type C disease. Biochim Biophys Acta. 1043:1990;123-128.
74. Butler J.D., Blanchette-Mackie J., Goldin E., O'Neill R.R., Carstea G., Roff C.F., Patterson M.C., Patel S., Comly M.E., Cooney A.et al. Progesterone blocks cholesterol translocation from lysosomes. J Biol Chem. 267:1992;23797-23805.
75. Roff C.F., Goldin E., Comly M.E., Cooney A., Brown A., Vanier M.T., Miller S.P., Brady R.O., Pentchev P.G. Type C Niemann-Pick disease: use of hydrophobic amines to study defective cholesterol transport. Dev Neurosci. 13:1991;315-319.
76. Lange Y., Steck T.L. Cholesterol homeostasis. Modulation by amphiphiles. J Biol Chem. 269:1994;29371-29374.
77. Underwood K.W., Andemariam B., McWilliams G.L., Liscum L. Quantitative analysis of hydrophobic amine inhibition of intracellular cholesterol transport. J Lipid Res. 37:1996;1556-1568.
78. Liscum L., Faust J.R. The intracellular transport of low density lipoprotein-derived cholesterol is inhibited in Chinese hamster ovary cells cultured with 3-beta-[2-(diethylamino)ethoxy]androst-5-en-17-one. J Biol Chem. 264:1989;11796-11806.
79. Yoshikawa H. Effects of drugs on cholesterol esterification in normal and Niemann-Pick type C fibroblasts: AY-9944, other cationic amphiphilic drugs and DMSO. Brain Dev. 13:1991;115-120.
80. Taylor A.M., Nakano Y., Mohler J., Ingham P.W. Contrasting distributions of patched and hedgehog proteins in the Drosophila embryo. Mech Dev. 42:1993;89-96.
81. Capdevila J., Pariente F., Sampedro J., Alonso J.L., Guerro I. Subcellular localization of the segment polarity protein patched suggests an interaction with the wingless reception complex in Drosophila embryos. Development. 120:1994;987-998.
82. Tabata T., Kornberg T.B. Hedgehog is a signaling protein with a key role in patterning Drosophila imaginal discs. Cell. 76:1994;89-102.
83. Bellaiche Y., The I., Perrimon N. Tout-velu is a Drosophila homologue of the putative tumour suppressor EXT-1 and is needed for Hh diffusion. Nature. 394:1998;85-88.
84. Goldstein J.L., Brown M.S. Regulation of the mevalonate pathway. Nature. 343:1990;425-430.
85. Braverman N., Lin P., Moebius F.F., Obie C., Moser A., Glossmann H., Wilcox W.R., Rimoin D.L., Smith M., Kratz L.et al. Mutations in the gene encoding 3 beta-hydroxysteroid-delta 8, delta 7- isomerase cause X-linked dominant Conradi-Hunermann syndrome. Nat Genet. 22:1999;291-294.
86. Derry J.M., Gormally E., Means G.D., Zhao W., Meindl A., Kelley R.I., Boyd Y., Herman G.E. Mutations in a delta 8-delta 7 sterol isomerase in the tattered mouse and X-linked dominant chondrodysplasia punctata. Nat Genet. 22:1999;286-290.
87. Kelley R.I., Wilcox W.G., Smith M., Kratz L.E., Moser A., Rimoin D.S. Abnormal sterol metabolism in patients with Conradi-Hunermann-Happle syndrome and sporadic lethal chondrodysplasia punctata. Am J Med Genet. 83:1999;213-219.
88. Liu X.Y., Dangel A.W., Kelley R.I., Zhao W., Denny P., Botcherby M., Cattanach B., Peters J., Huniscker P.R., Mallon A.M.et al. The gene mutated in bare patches and striated mice encodes a novel 3beta-hydroxysteroid dehydrogenase. Nat Genet. 22:1999;182-187.
89. Lange Y., Duan H., Mazzone T. Cholesterol homeostasis is modulated by amphiphiles at transcriptional and post-transcriptional loci. J Lipid Res. 37:1996;534-539.
90. Vanier M.T., Rodriguez-Lafrasse C., Rousson R., Mandon G., Boue J., Choiset A., Peyrat M.F., Dumontel C., Juge M.C., Pentchev P.G.et al. Prenatal diagnosis of Niemann-Pick type C disease: current strategy from an experience of 37 pregnancies at risk. Am J Hum Genet. 51:1992;111-122.
91. Gaffield W., Keeler R.F. Craniofacial malformations induced in hamsters by steroidal alkaloids. J Nat Toxins. 5:1996;25-38.
92. Lange Y., Ye Y., Rigney M., Steck T.L. Regulation of endoplasmic reticulum cholesterol by plasma membrane cholesterol. J Lipid Res. 40:1999;1-7.
93. Ruvkun G., Hobert O. The taxonomy of developmental control in Caenorhabditis elegans. Science. 282:1998;2033-2041.
94. Stone D.M., Hynes M., Armanini M., Swanson T.A., Gu Q., Johnson R.L., Scott M.P., Pennica D., Goddard A., Phillips H.et al. The tumour-suppressor gene patched encodes a candidate receptor for Sonic hedgehog. Nature. 384:1996;129-134.
95. Chen Y., Struhl G. In vivo evidence that Patched and Smoothened constitute distinct binding and transducing components of a Hedgehog receptor complex. Development. 125:1998;4943-4948.
96. Murone M., Rosenthal A., de Sauvage F.J. Sonic hedgehog signaling by the patched-smoothened receptor complex. Curr Biol. 9:1999;76-84.
97. Burke R., Nellen D., Bellotto M., Hafen E., Senti K.A., Dickson B.J., Basler K. Dispatched, a novel sterol-sensing domain protein dedicated to the release of cholesterol-modified hedgehog from signaling cells. Cell. 99:1999;803-815. Recent data suggest that even the release of Hh may be regulated by cholesterol. A gene called dispatched was identified in a screen for mutations with a Hedgehog-like phenotype. Like patched, it has sterol-sensing domain but seems to be required for the release of Hh from the cells that synthesize it. Intriguingly, dispatched does not facilitate the release of GPI-anchored Hh, suggesting that the release of normal cholesterol-modified Hh is not simply related to raft association.